APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy CRO Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell and Gene Therapy CRO Service Market Analysis and Forecast 2026-2032

1 January 2026198 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy CRO Service Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy CRO Service Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy CRO Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy CRO Service Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy CRO Service Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy CRO Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell and Gene Therapy CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell and Gene Therapy CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell and Gene Therapy CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell and Gene Therapy CRO Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell and Gene Therapy CRO Service include PPD, Medpace, Labcorp, Veristat, Charles River Laboratories, Premier Research, Catalent, IQVIA and Vial, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell and Gene Therapy CRO Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell and Gene Therapy CRO Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell and Gene Therapy CRO Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell and Gene Therapy CRO Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell and Gene Therapy CRO Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell and Gene Therapy CRO Service revenue, projected growth trends, production technology, application and end-user industry.

Cell and Gene Therapy CRO Service Segment by Company

PPD

Medpace

Labcorp

Veristat

Charles River Laboratories

Premier Research

Catalent

IQVIA

Vial

Noble Life Sciences

Ergomed

Cell and Gene Therapy CRO Service Segment by Type

Preclinical CRO

Clinical Stage CRO

Others

Cell and Gene Therapy CRO Service Segment by Application

Hospital

Research Institute

Others

Cell and Gene Therapy CRO Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy CRO Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy CRO Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy CRO Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell and Gene Therapy CRO Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell and Gene Therapy CRO Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy CRO Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Preclinical CRO Major Player Table 3. Clinical Stage CRO Major Player Table 4. Others Major Player Table 5. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Player Table 7. Research Institute Major Player Table 8. Others Major Player Table 9. Cell and Gene Therapy CRO Service Industry Trends Table 10. Cell and Gene Therapy CRO Service Industry Drivers Table 11. Cell and Gene Therapy CRO Service Industry Opportunities and Challenges Table 12. Cell and Gene Therapy CRO Service Industry Restraints Table 13. Global Cell and Gene Therapy CRO Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Cell and Gene Therapy CRO Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Cell and Gene Therapy CRO Service Market Share by Region (2021-2026) Table 16. Global Cell and Gene Therapy CRO Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Cell and Gene Therapy CRO Service Market Share by Region (2027-2032) Table 18. Global Cell and Gene Therapy CRO Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Cell and Gene Therapy CRO Service Revenue Market Share by Players (2021-2026) Table 20. Global Cell and Gene Therapy CRO Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Cell and Gene Therapy CRO Service Key Players Headquarters & Area Served Table 22. Global Cell and Gene Therapy CRO Service Players, Product Type & Application Table 23. Global Cell and Gene Therapy CRO Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Cell and Gene Therapy CRO Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Cell and Gene Therapy CRO Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Cell and Gene Therapy CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Cell and Gene Therapy CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Cell and Gene Therapy CRO Service Revenue Market Share by Type (2021-2026) Table 30. Global Cell and Gene Therapy CRO Service Revenue Market Share by Type (2027-2032) Table 31. Global Cell and Gene Therapy CRO Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Cell and Gene Therapy CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Cell and Gene Therapy CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2021-2026) Table 35. Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2027-2032) Table 36. PPD Company Information Table 37. PPD Business Overview Table 38. PPD Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. PPD Cell and Gene Therapy CRO Service Product Portfolio Table 40. PPD Recent Development Table 41. Medpace Company Information Table 42. Medpace Business Overview Table 43. Medpace Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Medpace Cell and Gene Therapy CRO Service Product Portfolio Table 45. Medpace Recent Development Table 46. Labcorp Company Information Table 47. Labcorp Business Overview Table 48. Labcorp Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Labcorp Cell and Gene Therapy CRO Service Product Portfolio Table 50. Labcorp Recent Development Table 51. Veristat Company Information Table 52. Veristat Business Overview Table 53. Veristat Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Veristat Cell and Gene Therapy CRO Service Product Portfolio Table 55. Veristat Recent Development Table 56. Charles River Laboratories Company Information Table 57. Charles River Laboratories Business Overview Table 58. Charles River Laboratories Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Charles River Laboratories Cell and Gene Therapy CRO Service Product Portfolio Table 60. Charles River Laboratories Recent Development Table 61. Premier Research Company Information Table 62. Premier Research Business Overview Table 63. Premier Research Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Premier Research Cell and Gene Therapy CRO Service Product Portfolio Table 65. Premier Research Recent Development Table 66. Catalent Company Information Table 67. Catalent Business Overview Table 68. Catalent Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Catalent Cell and Gene Therapy CRO Service Product Portfolio Table 70. Catalent Recent Development Table 71. IQVIA Company Information Table 72. IQVIA Business Overview Table 73. IQVIA Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. IQVIA Cell and Gene Therapy CRO Service Product Portfolio Table 75. IQVIA Recent Development Table 76. Vial Company Information Table 77. Vial Business Overview Table 78. Vial Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Vial Cell and Gene Therapy CRO Service Product Portfolio Table 80. Vial Recent Development Table 81. Noble Life Sciences Company Information Table 82. Noble Life Sciences Business Overview Table 83. Noble Life Sciences Cell and Gene Therapy CRO Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Noble Life Sciences Cell and Gene Therapy CRO Service Product Portfolio Table 85. Noble Life Sciences Recent Development Table 86. Ergomed Company Information Table 87. Ergomed Business Overview Table 88. Ergomed Cell and Gene Therapy CRO Service Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Ergomed Cell and Gene Therapy CRO Service Product Portfolio Table 90. Ergomed Recent Development Table 91. North America Cell and Gene Therapy CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Cell and Gene Therapy CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Cell and Gene Therapy CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 94. North America Cell and Gene Therapy CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 95. North America Cell and Gene Therapy CRO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 96. North America Cell and Gene Therapy CRO Service Revenue by Country (2021-2026) & (US$ Million) Table 97. North America Cell and Gene Therapy CRO Service Revenue by Country (US$ Million) & (2027-2032) Table 98. Europe Cell and Gene Therapy CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 99. Europe Cell and Gene Therapy CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 100. Europe Cell and Gene Therapy CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 101. Europe Cell and Gene Therapy CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 102. Europe Cell and Gene Therapy CRO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Cell and Gene Therapy CRO Service Revenue by Country (2021-2026) & (US$ Million) Table 104. Europe Cell and Gene Therapy CRO Service Revenue by Country (US$ Million) & (2027-2032) Table 105. China Cell and Gene Therapy CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 106. China Cell and Gene Therapy CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 107. China Cell and Gene Therapy CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 108. China Cell and Gene Therapy CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 109. Asia Cell and Gene Therapy CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 110. Asia Cell and Gene Therapy CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 111. Asia Cell and Gene Therapy CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 112. Asia Cell and Gene Therapy CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 113. Asia Cell and Gene Therapy CRO Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 114. Asia Cell and Gene Therapy CRO Service Revenue by Region (US$ Million) & (2021-2026) Table 115. Asia Cell and Gene Therapy CRO Service Revenue by Region (US$ Million) & (2027-2032) Table 116. SAMEA Cell and Gene Therapy CRO Service Revenue by Type (2021-2026) & (US$ Million) Table 117. SAMEA Cell and Gene Therapy CRO Service Revenue by Type (2027-2032) & (US$ Million) Table 118. SAMEA Cell and Gene Therapy CRO Service Revenue by Application (2021-2026) & (US$ Million) Table 119. SAMEA Cell and Gene Therapy CRO Service Revenue by Application (2027-2032) & (US$ Million) Table 120. SAMEA Cell and Gene Therapy CRO Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. SAMEA Cell and Gene Therapy CRO Service Revenue by Country (2021-2026) & (US$ Million) Table 122. SAMEA Cell and Gene Therapy CRO Service Revenue by Country (US$ Million) & (2027-2032) Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Cell and Gene Therapy CRO Service Image Figure 2. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell and Gene Therapy CRO Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Preclinical CRO Image Figure 5. Clinical Stage CRO Image Figure 6. Others Image Figure 7. Global Cell and Gene Therapy CRO Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Cell and Gene Therapy CRO Service Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Research Institute Image Figure 11. Others Image Figure 12. Global Cell and Gene Therapy CRO Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Cell and Gene Therapy CRO Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Cell and Gene Therapy CRO Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Cell and Gene Therapy CRO Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Cell and Gene Therapy CRO Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Cell and Gene Therapy CRO Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Cell and Gene Therapy CRO Service Revenue Market Share by Type (2021-2032) Figure 20. Global Cell and Gene Therapy CRO Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2021-2032) Figure 23. North America Cell and Gene Therapy CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032) Figure 25. North America Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032) Figure 26. North America Cell and Gene Therapy CRO Service Revenue Share by Country (2021-2032) Figure 27. United States Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Cell and Gene Therapy CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032) Figure 32. Europe Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032) Figure 33. Europe Cell and Gene Therapy CRO Service Revenue Share by Country (2021-2032) Figure 34. Germany Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Cell and Gene Therapy CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032) Figure 44. China Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032) Figure 45. Asia Cell and Gene Therapy CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032) Figure 47. Asia Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032) Figure 48. Asia Cell and Gene Therapy CRO Service Revenue Share by Region (2021-2032) Figure 49. Japan Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Cell and Gene Therapy CRO Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Cell and Gene Therapy CRO Service Revenue Share by Country (2021-2032) Figure 59. Brazil Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Cell and Gene Therapy CRO Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical Stage CRO
  • Others
Applications
  • Hospital
  • Research Institute
  • Others
Companies covered
  • PPD
  • Medpace
  • Labcorp
  • Veristat
  • Charles River Laboratories
  • Premier Research
  • Catalent
  • IQVIA
  • Vial
  • Noble Life Sciences
  • Ergomed

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell and Gene Therapy CRO Service Market by Type
  3. 1.2.1 Global Cell and Gene Therapy CRO Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Preclinical CRO
  5. 1.2.3 Clinical Stage CRO
  6. 1.2.4 Others
  7. 1.3 Cell and Gene Therapy CRO Service Market by Application
  8. 1.3.1 Global Cell and Gene Therapy CRO Service Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Research Institute
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Cell and Gene Therapy CRO Service Market Dynamics
  1. 2.1 Cell and Gene Therapy CRO Service Industry Trends
  2. 2.2 Cell and Gene Therapy CRO Service Industry Drivers
  3. 2.3 Cell and Gene Therapy CRO Service Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy CRO Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell and Gene Therapy CRO Service Market Perspective (2021-2032)
  2. 3.2 Global Cell and Gene Therapy CRO Service Growth Trends by Region
  3. 3.2.1 Global Cell and Gene Therapy CRO Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell and Gene Therapy CRO Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell and Gene Therapy CRO Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell and Gene Therapy CRO Service Revenue by Players
  2. 4.1.1 Global Cell and Gene Therapy CRO Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell and Gene Therapy CRO Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell and Gene Therapy CRO Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell and Gene Therapy CRO Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell and Gene Therapy CRO Service Key Players Headquarters & Area Served
  7. 4.4 Global Cell and Gene Therapy CRO Service Players, Product Type & Application
  8. 4.5 Global Cell and Gene Therapy CRO Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell and Gene Therapy CRO Service Market CR5 and HHI
  11. 4.6.3 2025 Cell and Gene Therapy CRO Service Tier 1, Tier 2, and Tier 3
5 Cell and Gene Therapy CRO Service Market Size by Type
  1. 5.1 Global Cell and Gene Therapy CRO Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy CRO Service Revenue by Type (2021-2032)
  3. 5.3 Global Cell and Gene Therapy CRO Service Revenue Market Share by Type (2021-2032)
6 Cell and Gene Therapy CRO Service Market Size by Application
  1. 6.1 Global Cell and Gene Therapy CRO Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell and Gene Therapy CRO Service Revenue by Application (2021-2032)
  3. 6.3 Global Cell and Gene Therapy CRO Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 PPD
  2. 7.1.1 PPD Company Information
  3. 7.1.2 PPD Business Overview
  4. 7.1.3 PPD Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 PPD Cell and Gene Therapy CRO Service Product Portfolio
  6. 7.1.5 PPD Recent Developments
  7. 7.2 Medpace
  8. 7.2.1 Medpace Company Information
  9. 7.2.2 Medpace Business Overview
  10. 7.2.3 Medpace Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Medpace Cell and Gene Therapy CRO Service Product Portfolio
  12. 7.2.5 Medpace Recent Developments
  13. 7.3 Labcorp
  14. 7.3.1 Labcorp Company Information
  15. 7.3.2 Labcorp Business Overview
  16. 7.3.3 Labcorp Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Labcorp Cell and Gene Therapy CRO Service Product Portfolio
  18. 7.3.5 Labcorp Recent Developments
  19. 7.4 Veristat
  20. 7.4.1 Veristat Company Information
  21. 7.4.2 Veristat Business Overview
  22. 7.4.3 Veristat Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Veristat Cell and Gene Therapy CRO Service Product Portfolio
  24. 7.4.5 Veristat Recent Developments
  25. 7.5 Charles River Laboratories
  26. 7.5.1 Charles River Laboratories Company Information
  27. 7.5.2 Charles River Laboratories Business Overview
  28. 7.5.3 Charles River Laboratories Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Charles River Laboratories Cell and Gene Therapy CRO Service Product Portfolio
  30. 7.5.5 Charles River Laboratories Recent Developments
  31. 7.6 Premier Research
  32. 7.6.1 Premier Research Company Information
  33. 7.6.2 Premier Research Business Overview
  34. 7.6.3 Premier Research Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Premier Research Cell and Gene Therapy CRO Service Product Portfolio
  36. 7.6.5 Premier Research Recent Developments
  37. 7.7 Catalent
  38. 7.7.1 Catalent Company Information
  39. 7.7.2 Catalent Business Overview
  40. 7.7.3 Catalent Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Catalent Cell and Gene Therapy CRO Service Product Portfolio
  42. 7.7.5 Catalent Recent Developments
  43. 7.8 IQVIA
  44. 7.8.1 IQVIA Company Information
  45. 7.8.2 IQVIA Business Overview
  46. 7.8.3 IQVIA Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 IQVIA Cell and Gene Therapy CRO Service Product Portfolio
  48. 7.8.5 IQVIA Recent Developments
  49. 7.9 Vial
  50. 7.9.1 Vial Company Information
  51. 7.9.2 Vial Business Overview
  52. 7.9.3 Vial Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Vial Cell and Gene Therapy CRO Service Product Portfolio
  54. 7.9.5 Vial Recent Developments
  55. 7.10 Noble Life Sciences
  56. 7.10.1 Noble Life Sciences Company Information
  57. 7.10.2 Noble Life Sciences Business Overview
  58. 7.10.3 Noble Life Sciences Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Noble Life Sciences Cell and Gene Therapy CRO Service Product Portfolio
  60. 7.10.5 Noble Life Sciences Recent Developments
  61. 7.11 Ergomed
  62. 7.11.1 Ergomed Company Information
  63. 7.11.2 Ergomed Business Overview
  64. 7.11.3 Ergomed Cell and Gene Therapy CRO Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Ergomed Cell and Gene Therapy CRO Service Product Portfolio
  66. 7.11.5 Ergomed Recent Developments
8 North America
  1. 8.1 North America Cell and Gene Therapy CRO Service Revenue (2021-2032)
  2. 8.2 North America Cell and Gene Therapy CRO Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell and Gene Therapy CRO Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell and Gene Therapy CRO Service Revenue by Type (2027-2032)
  5. 8.3 North America Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell and Gene Therapy CRO Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell and Gene Therapy CRO Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell and Gene Therapy CRO Service Revenue by Application (2027-2032)
  9. 8.5 North America Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell and Gene Therapy CRO Service Revenue by Country
  11. 8.6.1 North America Cell and Gene Therapy CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell and Gene Therapy CRO Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell and Gene Therapy CRO Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell and Gene Therapy CRO Service Revenue (2021-2032)
  2. 9.2 Europe Cell and Gene Therapy CRO Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell and Gene Therapy CRO Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell and Gene Therapy CRO Service Revenue by Type (2027-2032)
  5. 9.3 Europe Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell and Gene Therapy CRO Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell and Gene Therapy CRO Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell and Gene Therapy CRO Service Revenue by Application (2027-2032)
  9. 9.5 Europe Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell and Gene Therapy CRO Service Revenue by Country
  11. 9.6.1 Europe Cell and Gene Therapy CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell and Gene Therapy CRO Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell and Gene Therapy CRO Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell and Gene Therapy CRO Service Revenue (2021-2032)
  2. 10.2 China Cell and Gene Therapy CRO Service Revenue by Type (2021-2032)
  3. 10.2.1 China Cell and Gene Therapy CRO Service Revenue by Type (2021-2026)
  4. 10.2.2 China Cell and Gene Therapy CRO Service Revenue by Type (2027-2032)
  5. 10.3 China Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032)
  6. 10.4 China Cell and Gene Therapy CRO Service Revenue by Application (2021-2032)
  7. 10.4.1 China Cell and Gene Therapy CRO Service Revenue by Application (2021-2026)
  8. 10.4.2 China Cell and Gene Therapy CRO Service Revenue by Application (2027-2032)
  9. 10.5 China Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell and Gene Therapy CRO Service Revenue (2021-2032)
  2. 11.2 Asia Cell and Gene Therapy CRO Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell and Gene Therapy CRO Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell and Gene Therapy CRO Service Revenue by Type (2027-2032)
  5. 11.3 Asia Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell and Gene Therapy CRO Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell and Gene Therapy CRO Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell and Gene Therapy CRO Service Revenue by Application (2027-2032)
  9. 11.5 Asia Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell and Gene Therapy CRO Service Revenue by Country
  11. 11.6.1 Asia Cell and Gene Therapy CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell and Gene Therapy CRO Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell and Gene Therapy CRO Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell and Gene Therapy CRO Service Revenue (2021-2032)
  2. 12.2 SAMEA Cell and Gene Therapy CRO Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell and Gene Therapy CRO Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell and Gene Therapy CRO Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell and Gene Therapy CRO Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell and Gene Therapy CRO Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell and Gene Therapy CRO Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell and Gene Therapy CRO Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell and Gene Therapy CRO Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell and Gene Therapy CRO Service Revenue by Country
  11. 12.6.1 SAMEA Cell and Gene Therapy CRO Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell and Gene Therapy CRO Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell and Gene Therapy CRO Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst